Approvals/TGA/BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial

Approved

STANDARD

BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial

Medsurge Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f7e21ea717a667e4
Product Name: BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial
Artg Id: 427182
Artg Name: BIVALIRUDIN MEDSURGE bivalirudin (as trifluoroacetate) 250 mg powder for injection vial
Sponsor: Medsurge Pharma Pty Ltd
Company Detail Path: /organization/medsurge-pharma-pty-ltd
Artg Date: 2025-07-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f7e21ea717a667e4

Type

Standard